Cayuga Biotech
- Headquarters
- Ithaca, New York
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- cayugabiotech.com
- Total Funding
- $8.0M
- Last Round
- $8.0M SeedDec 2025
About
Cayuga Biotech is a clinical-stage biopharmaceutical company developing novel biomimetic therapies to address life-threatening hemorrhage. Leveraging inorganic polyphosphate, the company's first-in-class therapeutics harness the body's innate ability to stop bleeding, targeting noncompressible hemorrhage, coagulation dysfunction, and bleeding disorders. With over 3.5 million annual treatment opportunities, Cayuga addresses a $25B market.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account